Consistent with findings in HCC, low ZHX2 expression correlates with poor prognosis of thyroid cancer (7), multiple myeloma (8–10), and chronic lymphocytic leukemia (11, 12). This evidence concerns the gene ZHX2 and thyroid gland carcinoma.